ENTRY       N00046                      Network
NAME        Mutation-activated KIT to PI3K signaling pathway
DEFINITION  KIT* -> PI3K -> PIP3 -> AKT -| BAD
  EXPANDED  3815v1 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -| 572
CLASS       nt06214 PI3K signaling
            nt06275 Acute myeloid leukemia
TYPE        Variant
PATHWAY     hsa05221  Acute myeloid leukemia
DISEASE     H00003  Acute myeloid leukemia
GENE        3815  KIT; KIT proto-oncogene receptor tyrosine kinase
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
            207  AKT1; AKT serine/threonine kinase 1
            208  AKT2; AKT serine/threonine kinase 2
            10000  AKT3; AKT serine/threonine kinase 3
            572  BAD; BCL2 associated agonist of cell death
VARIANT     3815v1  KIT kinase domain mutation
METABOLITE  C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:19540337
  AUTHORS   Masson K, Ronnstrand L
  TITLE     Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3.
  JOURNAL   Cell Signal 21:1717-26 (2009)
            DOI:10.1016/j.cellsig.2009.06.002
REFERENCE   PMID:15625120
  AUTHORS   Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  TITLE     Normal and oncogenic forms of the receptor tyrosine kinase kit.
  JOURNAL   Stem Cells 23:16-43 (2005)
            DOI:10.1634/stemcells.2004-0117
REFERENCE   PMID:16236521
  AUTHORS   Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  TITLE     The molecular pathogenesis of acute myeloid leukemia.
  JOURNAL   Crit Rev Oncol Hematol 56:195-221 (2005)
            DOI:10.1016/j.critrevonc.2004.10.012
///
